Recursion firma acuerdos para la adquisición de Cyclica y Valence para fortalecer capacidades de química e IA generativa
09 mai 2023 19h34 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY y TORONTO y MONTREAL, May 09, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), una empresa líder de tecnobiología en etapa clínica con la decodificación de biología para la...
Recursion conclut des accords pour acquérir Cyclica et Valence en vue de renforcer ses capacités en chimie et de l'IA générative
09 mai 2023 19h34 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, TORONTO et MONTRÉAL, 10 mai 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ : RXRX), une société de biotechnologie au stade clinique de premier plan qui décode la biologie pour...
Recursion schließt Übernahmevereinbarungen für Cyclica und Valence zur Stärkung der Fähigkeiten in den Bereichen Chemie und generative KI ab
09 mai 2023 19h34 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY und TORONTO und MONTRÉAL, May 10, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), ein führendes, im klinischen Stadium tätiges TechBio-Unternehmen, das die Biologie...
Recursion ने केमिस्ट्री और जनरेटिव AI क्षमताओं को सहारा देने हेतु Cyclica and Valence का अधिग्रहण करने के लिए समझौते किए
09 mai 2023 19h34 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY और TORONTO और MONTRÉAL, May 10, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), जो कि औषधि की खोज को औद्योगीकृत करने के लिए बाय़ोलॉजी को डिकोड करने वाली एक प्रमुख क्लीनिकल...
Recursion Provides Business Updates and Reports First Quarter 2023 Financial Results
08 mai 2023 08h14 HE
|
Recursion Pharmaceuticals
Entered into agreements to acquire Cyclica and Valence to bolster digital chemistry and generative AI capabilities in order to further create new chemical composition of matter for novel biological...
Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities
08 mai 2023 07h59 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY and TORONTO and MONTRÉAL, May 08, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery,...
Recursion to Participate in Upcoming Investor Conferences
02 mai 2023 08h30 HE
|
Recursion Pharmaceuticals
Salt Lake City, May 02, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery, today announced its...
Recursion to Participate in Upcoming Investor Conference
03 avr. 2023 08h30 HE
|
Recursion Pharmaceuticals
Salt Lake City, April 03, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery, today announced...
Recursion Publishes Second Annual Environmental, Social and Governance Report
28 mars 2023 16h14 HE
|
Recursion Pharmaceuticals
Salt Lake City, March 28, 2023 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery, today announced...
Recursion to Participate in Upcoming Investor Conferences
01 mars 2023 08h00 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, March 01, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery, today announced...